Research & Development
European Union's drug regulator considers longer approval process for COVID-19 vaccines to be safer
2 December 2020 -

The drug regulator for the European Union has stated that its longer approval process for COVID-19 vaccines is safer, Reuters news agency reported on Wednesday.

Emergency authorisation of Pfizer and BioNTech's COID-19 vaccine has been granted by the UK regulator.

Reuters quoted the European Medicines Agency as saying: "EMA considers that the conditional marketing authorisation is the most appropriate regulatory mechanism for use in the current pandemic emergency."

It added that procedure was based on more evidence and more checks than the emergency procedure chosen by the UK.

EMA has said that it will decide on authorisation of Pfizer's vaccine by 29 December 2020.



Related Headlines